Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial (2015)
- Authors:
- USP affiliated authors: BRUNONI, ANDRÉ RUSSOWSKY - RUSP ; BENSEÑOR, ISABELA JUDITH MARTINS - FM ; LOTUFO, PAULO ANDRADE - FM ; GATTAZ, WAGNER FARID - FM
- Unidades: RUSP; FM
- DOI: 10.1016/j.jad.2015.07.006
- Subjects: BIOMARCADORES; DEPRESSÃO; SINIAS E SINTOMAS; DROGATERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Affective Disorders
- ISSN: 0165-0327
- Volume/Número/Paginação/Ano: v. 185, p. p. 209-213, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BRUNONI, André R. et al. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial. Journal of Affective Disorders, v. 185, p. 209-213, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2015.07.006. Acesso em: 27 dez. 2025. -
APA
Brunoni, A. R., Machado-Vieira, R., Sampaio-Junior, B., Vieira, E. L. M., Valiengo, L., Benseñor, I. M., et al. (2015). Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial. Journal of Affective Disorders, 185, 209-213. doi:10.1016/j.jad.2015.07.006 -
NLM
Brunoni AR, Machado-Vieira R, Sampaio-Junior B, Vieira ELM, Valiengo L, Benseñor IM, Lotufo PA, Carvalho AF, Cho HJ, Gattaz WF, Teixeira AL. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial [Internet]. Journal of Affective Disorders. 2015 ; 185 209-213.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.jad.2015.07.006 -
Vancouver
Brunoni AR, Machado-Vieira R, Sampaio-Junior B, Vieira ELM, Valiengo L, Benseñor IM, Lotufo PA, Carvalho AF, Cho HJ, Gattaz WF, Teixeira AL. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial [Internet]. Journal of Affective Disorders. 2015 ; 185 209-213.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.jad.2015.07.006 - Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
- Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study
- Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis.
- Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial
- A systematic review of non-invasive brain stimulation therapies and cardiovascular risk: implications for the treatment of major depressive disorder
- Association of mental health symptoms with the migraine-tension-type headache spectrum in the Brazilian longitudinal study of adult health
- Cognitive control therapy and transcranial direct current stimulation for depression: A randomized, double-blinded, controlled trial
- Suicide rates and income in São Paulo and Brazil: a temporal and spatial epidemiologic analysis from 1996 to 2008
- Acute working memory improvement after tDCS in antidepressant-free patients with major depressive disorder
- Effects of acute transcranial direct current stimulation in hot and cold working memory tasks in healthy and depressed subjects
Informações sobre o DOI: 10.1016/j.jad.2015.07.006 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
